Among 169,649 patients with MASLD, GLP-1 receptor agonist initiation was linked to significantly lower probability of incident cirrhosis [adjusted hazard ratio (aHR): 0.86, 95%CI: 0.80-0.93], hepatic decompensation (aHR: 0.77, 95%CI: 0.65-0.90), and hepatocellular carcinoma (HCC) (aHR: 0.79, 95%CI: 0.68-0.92) over a median follow-up of 3.5 years compared to non-users
Semaglutide labeling warns that patients with a history of diabetic retinopathy should be monitored for progression
The weekly monitoring can catch problems early before they become reasons to discontinue treatment
Cost depends on which GLP-1 medication fits you and your dose, and we'd rather give you a real number than a teaser rate so we go over exact pricing, in plain terms, at your consultation
[8] People affected by this condition show greater reduction in psychomotor functions on alcohol consumption than those without
The active ingredient in this medication is retatrutide